• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载高活性阿霉素衍生物的固体脂质纳米粒的研制与表征

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.

作者信息

Stella Barbara, Peira Elena, Dianzani Chiara, Gallarate Marina, Battaglia Luigi, Gigliotti Casimiro Luca, Boggio Elena, Dianzani Umberto, Dosio Franco

机构信息

Dipartimento di Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.

Dipartimento di Scienze della Salute, University of Eastern Piedmont Amedeo Avogadro, Via P.Solaroli, 15, 28100 Novara, Italy.

出版信息

Nanomaterials (Basel). 2018 Feb 16;8(2):110. doi: 10.3390/nano8020110.

DOI:10.3390/nano8020110
PMID:29462932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853741/
Abstract

Solid lipid nanoparticles (SLNs) comprise a versatile drug delivery system that has been developed for the treatment of a variety of diseases. The present study will investigate the feasibility of entrapping an active doxorubicin prodrug (a squalenoyl-derivative) in SLNs. The doxorubicin derivative-loaded SLNs are spherically shaped, have a mean diameter of 300-400 nm and show 85% w/w drug entrapment efficiency. The effects on cell growth of loaded SLNs, free doxorubicin and the prodrug have been examined using cytotoxicity and colony-forming assays in both human ovarian cancer line A2780 wild-type and doxorubicin-resistant cells. Further assessments as to the treatment's ability to induce cell death by apoptosis have been carried out by analyzing annexin-V staining and the activation of caspase-3. The in vitro data demonstrate that the delivery of the squalenoyl-doxorubicin derivative by SLNs increases its cytotoxic activity, as well as its apoptosis effect. This effect was particularly evident in doxorubicin-resistant cells.

摘要

固体脂质纳米粒(SLNs)是一种多功能药物递送系统,已被开发用于治疗多种疾病。本研究将探讨在固体脂质纳米粒中包载活性阿霉素前药(一种角鲨烯酰衍生物)的可行性。载有阿霉素衍生物的固体脂质纳米粒呈球形,平均直径为300 - 400纳米,药物包封率为85%(重量/重量)。已使用细胞毒性和集落形成试验,在人卵巢癌细胞系A2780野生型和阿霉素耐药细胞中检测了载药固体脂质纳米粒、游离阿霉素和前药对细胞生长的影响。通过分析膜联蛋白V染色和半胱天冬酶-3的激活,进一步评估了该治疗诱导细胞凋亡的能力。体外数据表明,固体脂质纳米粒递送角鲨烯酰阿霉素衍生物可增强其细胞毒性活性及其凋亡效应。这种效应在阿霉素耐药细胞中尤为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/dfed988f2c37/nanomaterials-08-00110-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/304bfb3924e7/nanomaterials-08-00110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/d7841f912c69/nanomaterials-08-00110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/3ca17680ccfd/nanomaterials-08-00110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/d398b19c4a0a/nanomaterials-08-00110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/ecdf9f26692c/nanomaterials-08-00110-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/dfed988f2c37/nanomaterials-08-00110-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/304bfb3924e7/nanomaterials-08-00110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/d7841f912c69/nanomaterials-08-00110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/3ca17680ccfd/nanomaterials-08-00110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/d398b19c4a0a/nanomaterials-08-00110-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/ecdf9f26692c/nanomaterials-08-00110-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4303/5853741/dfed988f2c37/nanomaterials-08-00110-g006.jpg

相似文献

1
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.负载高活性阿霉素衍生物的固体脂质纳米粒的研制与表征
Nanomaterials (Basel). 2018 Feb 16;8(2):110. doi: 10.3390/nano8020110.
2
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies.携带阿霉素亲脂性衍生物的固体脂质纳米粒:制备、表征及体外细胞毒性研究
J Microencapsul. 2016 Jun;33(4):381-90. doi: 10.1080/02652048.2016.1202342. Epub 2016 Jun 29.
3
Bioconjugate-loaded solid lipid nanoparticles for enhanced anticancer drug delivery to brain cancer cells: An evaluation.载药的固体脂质纳米粒用于增强抗癌药物向脑癌细胞的递送:评价。
Indian J Med Res. 2022 Jul;156(1):139-148. doi: 10.4103/ijmr.IJMR_514_19.
4
Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.载有大黄素的固体脂质纳米粒的制备、表征及抗肿瘤活性研究。
Int J Pharm. 2012 Jul 1;430(1-2):238-46. doi: 10.1016/j.ijpharm.2012.03.027. Epub 2012 Mar 23.
5
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.利用载多柔比星固体脂质纳米粒改善乳腺癌治疗:新型精氨酸-甘氨酸-天冬氨酸三肽偶联、pH 敏感脂质的合成及纳米药物的体内外评价。
Biomed Pharmacother. 2019 Aug;116:109006. doi: 10.1016/j.biopha.2019.109006. Epub 2019 May 29.
6
pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.用于减少多药耐药癌细胞中P-糖蛋白介导的药物外排的pH响应性治疗性固体脂质纳米粒
Int J Nanomedicine. 2015 Aug 5;10:5035-48. doi: 10.2147/IJN.S86053. eCollection 2015.
7
Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.基于载多柔比星的蛙皮素肽修饰纳米载体的乳腺癌靶向化疗。
Drug Deliv. 2016 Oct;23(8):2697-2702. doi: 10.3109/10717544.2015.1049721. Epub 2015 Jul 23.
8
Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin.用于阿霉素靶向递送的半乳糖工程化固体脂质纳米粒
Colloids Surf B Biointerfaces. 2015 Oct 1;134:47-58. doi: 10.1016/j.colsurfb.2015.06.027. Epub 2015 Jun 19.
9
Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.采用质量源于设计方法,以单硬脂酸甘油酯为单一脂质制备姜黄素固体脂质纳米粒:对人乳腺癌细胞系的抗癌活性表征与评价
Curr Drug Deliv. 2018;15(9):1271-1283. doi: 10.2174/1567201815666180503120113.
10
A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.一种新型聚合物-脂质杂化纳米颗粒系统可增强阿霉素对多药耐药性人乳腺癌细胞的细胞毒性。
Pharm Res. 2006 Jul;23(7):1574-85. doi: 10.1007/s11095-006-0282-x. Epub 2006 Jun 24.

引用本文的文献

1
Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases.通过脂肪酸凝聚法制备的绿色固体脂质纳米粒:一种用于靶向脑血管和神经疾病药物的创新鼻腔给药工具。
Pharmaceutics. 2024 Aug 8;16(8):1051. doi: 10.3390/pharmaceutics16081051.
2
Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges.基于天然化合物的癌症治疗纳米药物:未来方向与挑战。
Drug Deliv Transl Res. 2024 Oct;14(10):2845-2916. doi: 10.1007/s13346-024-01649-z. Epub 2024 Jul 13.
3
Quercetin-loaded solid lipid nanoparticles exhibit antitumor activity and suppress the proliferation of triple-negative MDA-MB 231 breast cancer cells: implications for invasive breast cancer treatment.

本文引用的文献

1
Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates.通过阿霉素和环杷明共轭物自组装形成的异质纳米颗粒。
ACS Med Chem Lett. 2017 Aug 1;8(9):953-957. doi: 10.1021/acsmedchemlett.7b00262. eCollection 2017 Sep 14.
2
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.用于靶向脑部疾病的固体脂质纳米粒和纳米结构脂质载体的设计进展。
J Control Release. 2017 Oct 28;264:306-332. doi: 10.1016/j.jconrel.2017.08.033. Epub 2017 Aug 26.
3
Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.
槲皮素负载固体脂质纳米粒具有抗肿瘤活性,并抑制三阴性 MDA-MB-231 乳腺癌细胞的增殖:对浸润性乳腺癌治疗的意义。
Mol Biol Rep. 2023 Nov;50(11):9417-9430. doi: 10.1007/s11033-023-08848-w. Epub 2023 Oct 13.
4
Anthracycline chemicals with anthracyclinone structure exert antitumor effects by inhibiting angiogenesis and lymphangiogenesis in a xenografted gastric tumor model.具有蒽环酮结构的蒽环类化学物质通过在异种移植胃癌模型中抑制血管生成和淋巴管生成发挥抗肿瘤作用。
Gastric Cancer. 2023 Nov;26(6):863-877. doi: 10.1007/s10120-023-01412-2. Epub 2023 Jun 21.
5
Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment.固体脂质纳米粒:用于癌症治疗的多功能纳米载体。
Pharmaceutics. 2023 Mar 3;15(3):831. doi: 10.3390/pharmaceutics15030831.
6
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs.纳米载体:一种可靠的抗癌药物递送工具。
Pharmaceutics. 2022 Jul 28;14(8):1566. doi: 10.3390/pharmaceutics14081566.
7
Essential Oil-Loaded Solid Lipid Nanoparticles Modified With Chitosan-Folate: Evaluation of Encapsulation Efficiency, Cytotoxic and Pro-apoptotic Properties.壳聚糖-叶酸修饰的载精油固体脂质纳米粒:包封率、细胞毒性和促凋亡特性评估
Front Chem. 2022 Jun 22;10:904973. doi: 10.3389/fchem.2022.904973. eCollection 2022.
8
Development of Dapagliflozin Solid Lipid Nanoparticles as a Novel Carrier for Oral Delivery: Statistical Design, Optimization, In-Vitro and In-Vivo Characterization, and Evaluation.达格列净固体脂质纳米粒作为口服给药新型载体的研发:统计设计、优化、体外和体内表征及评价
Pharmaceuticals (Basel). 2022 May 2;15(5):568. doi: 10.3390/ph15050568.
9
DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment.γ-分泌酶抑制剂的DR-5和DLL-4单克隆抗体功能化脂质体纳米粒——一种三阴性乳腺癌治疗方法
Adv Pharm Bull. 2021 Sep;11(4):618-623. doi: 10.34172/apb.2021.070. Epub 2020 Oct 19.
10
Solid Lipid Particles for Lung Metastasis Treatment.用于治疗肺转移的固体脂质颗粒
Pharmaceutics. 2021 Jan 13;13(1):93. doi: 10.3390/pharmaceutics13010093.
循环脂蛋白:引导鲨烯化药物进入低密度脂蛋白聚集癌细胞的特洛伊木马。
Mol Ther. 2017 Jul 5;25(7):1596-1605. doi: 10.1016/j.ymthe.2017.05.016. Epub 2017 Jun 9.
4
Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery.将角鲨烯与吉西他滨缀合作为利用内源性脂蛋白进行药物传递的独特方法。
Nat Commun. 2017 May 30;8:15678. doi: 10.1038/ncomms15678.
5
Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.载脂蛋白E功能化的固体脂质纳米粒增强脑内药物递送:摄取机制与转运途径
Bioconjug Chem. 2017 Apr 19;28(4):995-1004. doi: 10.1021/acs.bioconjchem.6b00705. Epub 2017 Apr 5.
6
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment.载甲氨蝶呤前药凝聚相分离固体脂质纳米粒:用于神经胶质瘤治疗的初步研究。
Nanomedicine (Lond). 2017 Mar;12(6):639-656. doi: 10.2217/nnm-2016-0380. Epub 2017 Feb 10.
7
Skin toxicity in a patient with ovarian cancer treated with pegylated liposomal doxorubicin: A case report and review of the literature.聚乙二醇化脂质体阿霉素治疗卵巢癌患者的皮肤毒性:一例报告及文献复习
Oncol Lett. 2016 Dec;12(6):5332-5334. doi: 10.3892/ol.2016.5309. Epub 2016 Oct 24.
8
Lipid-Drug Conjugate for Enhancing Drug Delivery.用于增强药物递送的脂质-药物缀合物
Mol Pharm. 2017 May 1;14(5):1325-1338. doi: 10.1021/acs.molpharmaceut.6b01027. Epub 2017 Jan 24.
9
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies.携带阿霉素亲脂性衍生物的固体脂质纳米粒:制备、表征及体外细胞毒性研究
J Microencapsul. 2016 Jun;33(4):381-90. doi: 10.1080/02652048.2016.1202342. Epub 2016 Jun 29.
10
Solid lipid nanoparticles loaded with fluorescent-labelled Cyclosporine A: anti-inflammatory activity in vitro.负载荧光标记环孢素A的固体脂质纳米粒:体外抗炎活性
Protein Pept Lett. 2014;21(11):1157-62. doi: 10.2174/0929866521666140806164410.